- Home
- FENG vs PYPD Comparison
FENG vs PYPD Comparison
Compare FENG & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- PYPD
- Stock Information
- Founded
- FENG 1998
- PYPD 2008
- Country
- FENG China
- PYPD Israel
- Employees
- FENG N/A
- PYPD N/A
- Industry
- FENG Broadcasting
- PYPD Medical/Dental Instruments
- Sector
- FENG Industrials
- PYPD Health Care
- Exchange
- FENG Nasdaq
- PYPD Nasdaq
- Market Cap
- FENG 29.7M
- PYPD 30.1M
- IPO Year
- FENG 2011
- PYPD 2020
- Fundamental
- Price
- FENG $2.25
- PYPD $2.71
- Analyst Decision
- FENG
- PYPD Strong Buy
- Analyst Count
- FENG 0
- PYPD 2
- Target Price
- FENG N/A
- PYPD $10.50
- AVG Volume (30 Days)
- FENG 6.3K
- PYPD 12.4K
- Earning Date
- FENG 03-11-2025
- PYPD 05-07-2025
- Dividend Yield
- FENG N/A
- PYPD N/A
- EPS Growth
- FENG N/A
- PYPD N/A
- EPS
- FENG N/A
- PYPD N/A
- Revenue
- FENG $96,408,461.00
- PYPD N/A
- Revenue This Year
- FENG N/A
- PYPD N/A
- Revenue Next Year
- FENG N/A
- PYPD N/A
- P/E Ratio
- FENG N/A
- PYPD N/A
- Revenue Growth
- FENG 1.69
- PYPD N/A
- 52 Week Low
- FENG $1.67
- PYPD $2.37
- 52 Week High
- FENG $4.15
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- FENG 47.35
- PYPD 42.57
- Support Level
- FENG $2.10
- PYPD $2.66
- Resistance Level
- FENG $2.33
- PYPD $2.75
- Average True Range (ATR)
- FENG 0.11
- PYPD 0.12
- MACD
- FENG -0.00
- PYPD -0.01
- Stochastic Oscillator
- FENG 50.11
- PYPD 11.48
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.